Repligen Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Repligen heeft een totaal eigen vermogen van $2.0B en een totale schuld van $521.6M, wat de schuld-eigenvermogensverhouding op 25.9% brengt. De totale activa en totale passiva bedragen respectievelijk $2.8B en $814.0M. De EBIT Repligen is $25.7M waardoor de rentedekking -2.9 is. Het heeft contanten en kortetermijnbeleggingen van $784.0M.
Belangrijke informatie
25.9%
Verhouding schuld/eigen vermogen
US$521.61m
Schuld
| Rente dekkingsratio | -2.9x |
| Contant | US$783.96m |
| Aandelen | US$2.02b |
| Totaal verplichtingen | US$813.96m |
| Totaal activa | US$2.83b |
Recente financiële gezondheidsupdates
Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08
We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Recent updates
Repligen Corporation's Earnings Preview: Expensive With Mixed Growth Prospects
Nov 12Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08Is It Time To Consider Buying Repligen Corporation (NASDAQ:RGEN)?
Oct 14Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 28% Above Its Share Price
Sep 08Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 31We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen: Strong Filtration Growth, Offset By Other Challenges
Jul 13Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge
Jun 14Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?
Jun 10Repligen Stock: Still Quite Overvalued
May 30Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 03Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Apr 30Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?
Feb 13Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Jan 08Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price
Dec 19What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?
Nov 01Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?
Sep 29Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade
Aug 09Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?
Jul 03With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case
Jun 19Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $1.1B ) RGEN } overtreffen de korte termijn passiva ( $108.4M ).
Langlopende schulden: De kortetermijnactiva RGEN ( $1.1B ) overtreffen de langetermijnschulden ( $705.6M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: RGEN heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van RGEN is de afgelopen 5 jaar gestegen van 22% naar 25.9%.
Schuldendekking: De schuld van RGEN wordt goed gedekt door de operationele kasstroom ( 31.7% ).
Rentedekking: RGEN verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.